Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

The Ministry of Health (MoH) has assured that the leprosy situation in Kuala Pilah remains under control, with patients no ...

The Humane Society of the Pikes Peak Region (HSPPR) is temporarily limiting dog intakes after discovering multiple cases of ...

especially if the current treatment isn’t effective. A 2022 study found that only 24.9% of patients remained on their prescribed migraine prophylactic after 24 months. Among all patients ...

CSL and uniQure's Hemgenix shows sustained efficacy in hemophilia B, reducing bleeding rates by 90% and eliminating ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.CcrFU5Zy.js ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...

Defibrotide prophylaxis after HSCT did not reduce sinusoidal obstructive syndrome incidence in high-risk pediatric patients, per retrospective study at 2025 Tandem Meeting.

Gumisayi Bonzo, a director at Trans Smart Trust, an organisation offering HIV and Aids services to transgender and intersex ...

Data from the study showed that HEMGENIX continues to deliver sustained factor IX activity levels for up to four years post-treatment. The treatment also provides long-term bleed protection, ...